Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study

Oncology
J T HartmannC Bokemeyer

Abstract

To evaluate the therapeutic activity of 24-hour continuously infused 5-fluorouracil (5-FU) modulated by high-dose folinic acid in patients with metastatic colorectal cancer who had recurred or progressed following mainly bolus 5-FU/folinic acid chemotherapy. Forty-two patients with a median age of 59 years (45-76) were enrolled. Karnofsky status was 90% (80-100), previous chemotherapy regimen bolus 5-FU/folinic acid (n=33, 79%) or 24-hour continuous 5-FU+/-interferon alpha2 (n=9, 21 %). Chemotherapy was given as a weekly infusion of 500 mg/m2 folinic acid over 2 h followed by a 24-hour continuous infusion of 2,600 mg/m2 5-FU for 6 consecutive weeks followed by a 2-week rest period. No complete but 6 partial responses were observed (ORR: 14%, CI95%: 3.5-25.1%) with a median response duration of 7.3 months (range: 1.4-10.6). The median survival from the start of continuous infusion of 5-FU was 11.6 months (range: 2-27, CI95%: 9.4-13.8) and the 1-year survival rate was 46%. Disease stabilization and minor responses were achieved in another 25 patients (61%). WHO grade III/IV diarrhea occurred in 26% of patients, mucositis, nausea/vomiting and hand-foot syndrome in 5% each. Two cases of WHO grade III anemia and leukocytopenia were ...Continue Reading

Citations

Sep 15, 2004·Cancer Chemotherapy and Pharmacology·Gabriella CalvielloPaola Palozza
May 25, 2002·Journal of the American Geriatrics Society·Joanne P Robinson, Judy A Shea
Dec 13, 2002·American Journal of Clinical Oncology·Charalambos KouroussisVassilis Georgoulias
Dec 17, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H T SeeR C Bast
Oct 25, 2000·Alcoholism, Clinical and Experimental Research·Q ZhuD H Van Thiel
Feb 16, 2013·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Misty M MillerTracy M Hagemann
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D R MansG Schwartsmann
Oct 1, 2013·Critical Reviews in Oncology/hematology·Sally TemrazAli Shamseddine
Apr 22, 2005·Critical Reviews in Oncology/hematology·Lara Maria PasettoSilvio Monfardini
Sep 15, 2004·Critical Reviews in Oncology/hematology·Lara Maria PasettoSilvio Monfardini
Jun 19, 2019·Therapeutic Advances in Medical Oncology·Margherita RattiMichele Ghidini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

© 2022 Meta ULC. All rights reserved